Cannabis News and Research

Latest Cannabis News and Research

Cannabis Science expands market awareness program by joining www.StockProfile.com

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce today that they have expanded their market awareness program by joining www.StockProfile.com, a customized web-based platform showcasing emerging growth stocks.

27 Mar 2010

Marijuana must not be legalized in California, says opposition to the legalization initiative

The Opposition to the California Marijuana Legalization Initiative (2010) has learned that the ballot measure for The Regulate, Control and Tax Cannabis Act of 2010 has officially been certified by the State of California to qualify for the November ballot.

26 Mar 2010

Legalising cannabis: School children debate

Should cannabis be legalised? This thorny political issue will be debated by teams of school children in a national competition designed to challenge the pupil's scientific knowledge. The event is part of the Festival of Social Science organised by the Economic and Social Research Council (ESRC) and will be staged at the Royal Pharmaceutical Society of Great Britain.

11 Mar 2010

Non-smoked medical cannabis products needed, says National Drug Control Policy Deputy Director

Cannabis Science, Inc., a pioneering US pharmaceutical cannabis company, notes that comments by President Obama's Deputy Director of the White House Office of National Drug Control Policy, Tom McClellan, in yesterday's USA TODAY pinpoints the need for non-smoked medical cannabis products similar to those currently being developed for FDA clinical trials by Cannabis Science.

11 Mar 2010

Veterans PTSD Project: Cannabis Science formalizes agreement with specialized FDA regulatory compliance firm

Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.

11 Mar 2010

'Fake pot' can cause hallucinations and seizures

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures.

4 Mar 2010

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

3 Mar 2010

Long-time cannabis use linked to psychosis-related outcomes

Young adults who have used cannabis or marijuana for a longer period of time appear more likely to have hallucinations or delusions or to meet criteria for psychosis, according to a report posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Mar 2010

PTSD drug: Cannabis Science to file first application for FDA clinical trials

Cannabis Science Inc., a pharmaceutical cannabis company in the US, is pleased to announce that it now has the results of its survey of more than 1,300 individuals with PTSD, including a large cohort of veterans. The survey was conducted by Cannabis Science Advisory Board member Dr. Mitch Earleywine PhD. of the State University of New York (Albany).

2 Mar 2010

Cannabis Science completes selection of initial cannabis-based pharmaceutical for FDA clinical trials

Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company’s FDA filings.

25 Feb 2010

Recreational drugs can trigger memory lapse

Have you ever forgotten to post an important letter or let an appointment slip your mind? A new study from UK researchers suggests that for those who regularly use ecstasy or other recreational drugs, this kind of memory lapse is more common.

24 Feb 2010

Cannabis promising for certain pain-related medical conditions, CMCR presents findings to California legislature

Researchers from the University of California's Center for Medicinal Cannabis Research (CMCR) have found "reasonable evidence that cannabis is a promising treatment" for some specific, pain-related medical conditions. Their findings, presented today to the California legislature and public, are included in a report available on the CMCR web site at http://www.cmcr.ucsd.edu

18 Feb 2010

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.

17 Feb 2010

Exposure to ecstasy or cocaine during adolescence could lead to drug addiction

Exposure to ecstasy or cocaine during adolescence increases the "reinforcing effects" that make people vulnerable to developing an addiction. This is the main conclusion of a research team from the University of Valencia (UV), which has shown for the first time how these changes persist into adulthood.

5 Feb 2010

Illicit drug consumption in Europe

Europeans belong to the largest consumers of illicit drugs, absorbing about one fifth of the global heroin, cocaine and cannabis supply, as well as one third of ecstasy production (UNODC World Drug report, 2008). However, the vast majority of Europeans have never tried any illicit substance. In popular perception, illicit drugs still represent alien cultures challenging traditional European patterns, including consumption of our favourite drugs - alcoholic beverages.

21 Jan 2010

Medical Marijuana praises New Jersey State Assembly for removing state-wide penalties on marijuana use

Medical Marijuana Inc applauds the New Jersey State Assembly and Senate for having approved "The New Jersey Compassionate Use Medical Marijuana Act" on Monday, January 11, 2010. A804/S119 removes state-wide penalties for possession of up to two ounces of marijuana when a New Jersey licensed Physician recommends it for one of the qualified medical conditions including Aids, Cancer, Multiple Sclerosis and Crohn's disease among others.

13 Jan 2010

Medical Marijuana launches National Educational Expo at the Los Angeles Convention Center

Medical Marijuana Inc is proud to announce the launch of its first National Educational Expo at the Los Angeles Convention Center, Theatre Room on January 16 & 17, 2010.

5 Jan 2010

Marijuana lyrics linked to marijuana use

Teens who frequently listen to music that contains references to marijuana are more likely to use the drug than their counterparts with less exposure to such lyrics, according to a University of Pittsburgh School of Medicine study online now in the journal Addiction.

23 Dec 2009

Cannabis can cause depression and anxiety in teenagers

Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.

18 Dec 2009

Cannabis for Ulcerative Colitis and Crohn's Disease treatment

Chemicals found in cannabis could prove an effective treatment for the inflammatory bowel diseases Ulcerative Colitis and Crohn's Disease, say scientists.

17 Dec 2009

Cannabis News and Research

Latest Cannabis News and Research

Cannabis Science expands market awareness program by joining www.StockProfile.com

Marijuana must not be legalized in California, says opposition to the legalization initiative

Legalising cannabis: School children debate

Non-smoked medical cannabis products needed, says National Drug Control Policy Deputy Director

Veterans PTSD Project: Cannabis Science formalizes agreement with specialized FDA regulatory compliance firm

'Fake pot' can cause hallucinations and seizures

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

Long-time cannabis use linked to psychosis-related outcomes

PTSD drug: Cannabis Science to file first application for FDA clinical trials

Cannabis Science completes selection of initial cannabis-based pharmaceutical for FDA clinical trials

Recreational drugs can trigger memory lapse

Cannabis promising for certain pain-related medical conditions, CMCR presents findings to California legislature

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Exposure to ecstasy or cocaine during adolescence could lead to drug addiction

Illicit drug consumption in Europe

Medical Marijuana praises New Jersey State Assembly for removing state-wide penalties on marijuana use

Medical Marijuana launches National Educational Expo at the Los Angeles Convention Center

Marijuana lyrics linked to marijuana use

Cannabis can cause depression and anxiety in teenagers

Cannabis for Ulcerative Colitis and Crohn's Disease treatment

Cannabis Testing & Analysis eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut